[1]
Koo, E. and Macdonald, D.A. 2024. Maintenance Therapy for CD20+ Indolent Lymphoma: Who Should Receive Maintenance?. Canadian Hematology Today. 3, 1 (Apr. 2024), 44–50. DOI:https://doi.org/10.58931/cht.2024.3150.